343 results
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
6 Feb 12
Neptune, Aker and Schiff Agree to Stay of Litigation during Patent Re-examination Proceedings
12:00am
PRESS RELEASE
SOURCE: Neptune Technologies & Bioressources Inc.
Neptune, Aker and Schiff Agree to Stay of Litigation during Patent Re-examination … by the parties in the patent infringement litigation initiated by Neptune in the U.S. District Court in Delaware, the court has ordered a stay
40-F
2020 FY
EX-99.3
NEPTF
Neptune Wellness Solutions Inc
10 Jun 20
Annual report (Canada)
4:36pm
income. Other items such as stock-based compensation, litigation provisions, acquisition costs, change in fair value of contingent consideration … consideration
Stock-based compensation
Litigation provisions
Impairment loss on goodwill
Income tax expense
Adjusted EBITDA1
1 The Adjusted Segment
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
18 Jan 22
Current report (foreign)
11:02am
Counsel – Litigation
Christopher Piazza has been appointed to Deputy General Counsel – Corporate
LAVAL, QC, Jan. 18, 2022 /CNW/ - Neptune Wellness … ."
Effective immediately, Christopher J. C. Waldon has been appointed Deputy General Counsel – Litigation. Waldon joins Neptune from Venable LLP, where he
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
10 Jun 20
Neptune Reports Fourth Quarter and Fiscal 2020 Results
4:23pm
compensation, litigation provisions, acquisition costs, change in fair value of contingent consideration, impairment loss on goodwill and severance and related … -based compensation
Litigation provisions
Impairment loss on goodwill
Income tax expense
Adjusted EBITDA1
1The Adjusted Segment EBITDA and the Adjusted
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
12 Jun 19
Neptune Announces Fourth Quarter Results
4:14pm
million in the fourth quarter of fiscal 2019 versus a net loss of $4.8 million in the fourth quarter of fiscal 2018; variation reflecting litigation … ended March 31, 2018, reflecting litigation provisions of $7.9 million in the current quarter.
Non-IFRS operating loss1 was $2.7 million for the current
8-K
EX-99.1
kd4u4wmmhtjb
16 Aug 22
Neptune Reports Fiscal First Quarter 2023 Financial Results
12:19pm
6-K
EX-99.1
i268o4
6 Oct 11
Neptune Launches Patent Infringement Litigation against Aker Biomarine ASA, Enzymotec Ltd., and Others
12:00am
6-K
EX-99.1
qnz089a
11 Aug 20
Management Discussion and Analysis of the Financial Situation and Operating Results for the Three-month Periods Ended June 30, 2020 and 2019
4:10pm
8-K
EX-99.1
go5jllbfidyid 6gg
18 Jul 23
Neptune Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results
11:31am
40-F
EX-99.3
llv16qsle8
12 Jun 19
Annual report (Canada)
4:57pm
8-K
EX-99.1
p5yjo6w6pe0
8 Jul 22
Neptune Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results
2:50pm
8-K
EX-99.1
pdr1dpddq ic4y9okc
22 Aug 23
Neptune Reports Fiscal First Quarter 2024 Financial Results
4:16pm
8-K
EX-99.1
theu8zunyfd5 ru1nr
21 Dec 22
Neptune Reports Fiscal Second Quarter 2023 Financial Results
5:24pm
6-K
EX-99.1
sevzkfjc
12 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.2
2e7qdtiop1j6s05
11 Aug 20
Management Discussion and Analysis of the Financial Situation and Operating Results for the Three-month Periods Ended June 30, 2020 and 2019
4:10pm
6-K
EX-99.1
uvcqayaqs3
14 Aug 19
Management Discussion and Analysis of the Financial Situation and Operating Results for the Three-month Periods Ended June 30, 2019 and 2018
12:00am
F-10
46idh6f9pm3assq1aaa7
26 Mar 21
Registration of securities (Canada)
12:00am
6-K
EX-99.1
8yveguvr642d7ngs4cb3
27 Dec 11
Neptune welcomes the opportunity to reconfirm the validity of its ‘348 Patent
12:00am
6-K
EX-99.1
oqg2p
1 Oct 09
Neptune Technologies & Bioressources Inc. provides a Corporate and Operations Update
12:00am
6-K
EX-99.2
432cc3p91luxbp0
16 Nov 20
Current report (foreign)
4:05pm